Epstein–Barr virus (EBV) is the causative agent of infectious mononucleosis and a risk factor for developing a variety of lymphomas and carcinomas. EBV nuclear antigen 1 (EBNA1) is the only viral protein found in all EBV-related malignancies. It plays a key role in establishing and maintaining the altered state of cells transformed with EBV. EBNA1 is required for a variety of functions, including gene regulation, replication and maintenance of the viral genome, but the regulation of EBNA1's functions is poorly understood. We demonstrate that phosphorylation affects the functions of EBNA1. By using electron-transfer dissociation tandem mass spectrometry, ten specific phosphorylated EBNA1 residues were identified. A mutant derivative preventing the phosphorylation of all ten phosphosites retained the unusually long half-life and the ability to translocate into the nucleus of wild-type EBNA1. This phosphorylation-deficient mutant, however, had a significantly reduced ability to activate transcription and to maintain EBV's plasmids in cells.
Aiyar, A. & Sugden, B.(1998). Fusions between Epstein–Barr viral nuclear antigen-1 of Epstein–Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins. J Biol Chem273, 33073–33081.[CrossRef][Google Scholar]
Bergendahl, V., Glaser, B. T. & Burgess, R. R.(2003). A fast Western blot procedure improved for quantitative analysis by direct fluorescence labeling of primary antibodies. J Immunol Methods277, 117–125.[CrossRef][Google Scholar]
Coon, J. J., Syka, J. E. P., Schwartz, J. C., Shabanowitz, J. & Hunt, D. F.(2004). Anion dependence in the partitioning between proton and electron transfer in ion/ion reactions. Int J Mass Spectrom236, 33–42.[CrossRef][Google Scholar]
Crawford, D. H.(2001). Biology and disease associations of Epstein–Barr virus. Philos Trans R Soc Lond B Biol Sci356, 461–473.[CrossRef][Google Scholar]
Dhar, S. K., Yoshida, K., Machida, Y., Khaira, P., Chaudhuri, B., Wohlschlegel, J. A., Leffak, M., Yates, J. & Dutta, A.(2001). Replication from oriP of Epstein–Barr virus requires human ORC and is inhibited by geminin. Cell106, 287–296.[CrossRef][Google Scholar]
Duellman, S. J. & Burgess, R. R.(2006). Overproduction in Escherichia coli and purification of Epstein–Barr virus EBNA-1. Protein Expr Purif47, 434–440.[CrossRef][Google Scholar]
Duellman, S. J. & Burgess, R. R.(2009). Antigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatography. . PLoS One4, e4614[CrossRef][Google Scholar]
Fahraeus, R.(2005). Do peptides control their own birth and death? Nat Rev Mol Cell Biol6, 263–267.
[Google Scholar]
Frappier, L. & O'Donnell, M.(1991a). Epstein–Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein–Barr virus. Proc Natl Acad Sci U S A88, 10875–10879.[CrossRef][Google Scholar]
Frappier, L. & O'Donnell, M.(1991b). Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein–Barr virus. J Biol Chem266, 7819–7826.
[Google Scholar]
Freire, E., Oddo, C., Frappier, L. & de Prat-Gay, G.(2008). Kinetically driven refolding of the hyperstable EBNA1 origin DNA-binding dimeric β-barrel domain into amyloid-like spherical oligomers. Proteins70, 450–461.
[Google Scholar]
Gahn, T. A. & Sugden, B.(1995). An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein–Barr virus LMP gene. J Virol69, 2633–2636.
[Google Scholar]
Geer, L. Y., Markey, S. P., Kowalak, J. A., Wagner, L., Xu, M., Maynard, D. M., Yang, X., Shi, W. & Bryant, S. H.(2004). Open mass spectrometry search algorithm. J Proteome Res3, 958–964.[CrossRef][Google Scholar]
Goldsmith, K., Bendell, L. & Frappier, L.(1993). Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein–Barr virus latent origin of DNA replication. J Virol67, 3418–3426.
[Google Scholar]
Good, D. M., Wirtala, M., McAlister, G. C. & Coon, J. J.(2007). Performance characteristics of electron transfer dissociation mass spectrometry. Mol Cell Proteomics6, 1942–1951.[CrossRef][Google Scholar]
Hearing, J. C. & Levine, A. J.(1985). The Epstein–Barr virus nuclear antigen (BamHI K antigen) is a single-stranded DNA binding phosphoprotein. Virology145, 105–116.[CrossRef][Google Scholar]
Hietakangas, V., Anckar, J., Blomster, H. A., Fujimoto, M., Palvimo, J. J., Nakai, A. & Sistonen, L.(2006). PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci U S A103, 45–50.[CrossRef][Google Scholar]
Ito, S., Ikeda, M., Kato, N., Matsumoto, A., Ishikawa, Y., Kumakubo, S. & Yanagi, K.(2000). Epstein–Barr virus nuclear antigen-1 binds to nuclear transporter karyopherin α1/NPI-1 in addition to karyopherin α2/Rch1. Virology266, 110–119.[CrossRef][Google Scholar]
Kennedy, G. & Sugden, B.(2003). EBNA-1, a bifunctional transcriptional activator. Mol Cell Biol23, 6901–6908.[CrossRef][Google Scholar]
Kennedy, G., Komano, J. & Sugden, B.(2003). Epstein–Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A100, 14269–14274.[CrossRef][Google Scholar]
Kim, A. L., Maher, M., Hayman, J. B., Ozer, J., Zerby, D., Yates, J. L. & Lieberman, P. M.(1997). An imperfect correlation between DNA replication activity of Epstein–Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin α. Virology239, 340–351.[CrossRef][Google Scholar]
Kitamura, R., Sekimoto, T., Ito, S., Harada, S., Yamagata, H., Masai, H., Yoneda, Y. & Yanagi, K.(2006). Nuclear import of Epstein–Barr virus nuclear antigen 1 mediated by NPI-1 (importin α5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential. J Virol80, 1979–1991.[CrossRef][Google Scholar]
Lee, D. Y. & Sugden, B.(2008). The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood111, 2280–2289.[CrossRef][Google Scholar]
Lee, M. A., Diamond, M. E. & Yates, J. L.(1999). Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein–Barr virus. J Virol73, 2974–2982.
[Google Scholar]
Leight, E. R. & Sugden, B.(2000). EBNA-1: a protein pivotal to latent infection by Epstein–Barr virus. Rev Med Virol10, 83–100.[CrossRef][Google Scholar]
Leight, E. R. & Sugden, B.(2001). Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol21, 4149–4161.[CrossRef][Google Scholar]
Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. & Masucci, M. G.(1997). Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A94, 12616–12621.[CrossRef][Google Scholar]
Lin, D. I., Barbash, O., Kumar, K. G., Weber, J. D., Harper, J. W., Klein-Szanto, A. J., Rustgi, A., Fuchs, S. Y. & Diehl, J. A.(2006). Phosphorylation-dependent ubiquitination of cyclin D1 by the SCFFBX4-αB crystallin complex. Mol Cell24, 355–366.[CrossRef][Google Scholar]
Lindner, S. E., Zeller, K., Schepers, A. & Sugden, B.(2008). The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency. J Virol82, 5693–5702.[CrossRef][Google Scholar]
Lu, K. P., Liou, Y. C. & Zhou, X. Z.(2002). Pinning down proline-directed phosphorylation signaling. Trends Cell Biol12, 164–172.[CrossRef][Google Scholar]
Lusky, M. & Fontane, E.(1991). Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. Proc Natl Acad Sci U S A88, 6363–6367.[CrossRef][Google Scholar]
Mackey, D. & Sugden, B.(1999). The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol19, 3349–3359.
[Google Scholar]
Mackey, D., Middleton, T. & Sugden, B.(1995). Multiple regions within EBNA1 can link DNAs. J Virol69, 6199–6208.
[Google Scholar]
Martin, S. E., Shabanowitz, J., Hunt, D. F. & Marto, J. A.(2000). Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem72, 4266–4274.[CrossRef][Google Scholar]
McAlister, G. C., Phanstiel, D., Good, D. M., Berggren, W. T. & Coon, J. J.(2007). Implementation of electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer. Anal Chem79, 3525–3534.[CrossRef][Google Scholar]
McAlister, G. C., Berggren, W. T., Griep-Raming, J., Horning, S., Makarov, A., Phanstiel, D., Stafford, G., Swaney, D. L., Syka, J. E. & other authors(2008). A proteomics grade electron transfer dissociation-enabled hybrid linear ion trap-orbitrap mass spectrometer. J Proteome Res7, 3127–3136.[CrossRef][Google Scholar]
McBride, A. A. & Howley, P. M.(1991). Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number. J Virol65, 6528–6534.
[Google Scholar]
McBride, A. A., Bolen, J. B. & Howley, P. M.(1989). Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. J Virol63, 5076–5085.
[Google Scholar]
Menezes, J., Leibold, W., Klein, G. & Clements, G.(1975). Establishment and characterization of an Epstein–Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine22, 276–284.
[Google Scholar]
Middleton, T. & Sugden, B.(1992). EBNA1 can link the enhancer element to the initiator element of the Epstein–Barr virus plasmid origin of DNA replication. J Virol66, 489–495.
[Google Scholar]
Munz, C.(2004). Epstein–Barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target. J Exp Med199, 1301–1304.[CrossRef][Google Scholar]
Ndassa, Y. M., Orsi, C., Marto, J. A., Chen, S. & Ross, M. M.(2006). Improved immobilized metal affinity chromatography for large-scale phosphoproteomics applications. J Proteome Res5, 2789–2799.[CrossRef][Google Scholar]
Ohara, N., Hayashi, K., Teramoto, N., Oka, T., Fujimoto, K., Yoshikawa, Y., Castanos-Velez, E., Biberfeld, P. & Akagi, T.(2000). Sequence analysis and variation of EBNA-1 in Epstein–Barr virus-related herpesvirus of cynomolgus monkey. Intervirology43, 102–106.[CrossRef][Google Scholar]
Polvino-Bodnar, M., Kiso, J. & Schaffer, P. A.(1988). Mutational analysis of Epstein–Barr virus nuclear antigen 1 (EBNA 1). Nucleic Acids Res16, 3415–3435.[CrossRef][Google Scholar]
Ritzi, M., Tillack, K., Gerhardt, J., Ott, E., Humme, S., Kremmer, E., Hammerschmidt, W. & Schepers, A.(2003). Complex protein–DNA dynamics at the latent origin of DNA replication of Epstein–Barr virus. J Cell Sci116, 3971–3984.[CrossRef][Google Scholar]
Roscic, A., Moller, A., Calzado, M. A., Renner, F., Wimmer, V. C., Gresko, E., Ludi, K. S. & Schmitz, M. L.(2006). Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell24, 77–89.[CrossRef][Google Scholar]
Shah, W. A., Ambinder, R. F., Hayward, G. S. & Hayward, S. D.(1992). Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. J Virol66, 3355–3362.
[Google Scholar]
Shire, K., Kapoor, P., Jiang, K., Hing, M. N., Sivachandran, N., Nguyen, T. & Frappier, L.(2006). Regulation of the EBNA1 Epstein–Barr virus protein by serine phosphorylation and arginine methylation. J Virol80, 5261–5272.[CrossRef][Google Scholar]
Su, W., Middleton, T., Sugden, B. & Echols, H.(1991). DNA looping between the origin of replication of Epstein–Barr virus and its enhancer site: stabilization of an origin complex with Epstein–Barr nuclear antigen 1. Proc Natl Acad Sci U S A88, 10870–10874.[CrossRef][Google Scholar]
Sugden, B. & Warren, N.(1989). A promoter of Epstein–Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol63, 2644–2649.
[Google Scholar]
Swaney, D. L., McAlister, G. C., Wirtala, M., Schwartz, J. C., Syka, J. E. & Coon, J. J.(2007). Supplemental activation method for high-efficiency electron-transfer dissociation of doubly protonated peptide precursors. Anal Chem79, 477–485.[CrossRef][Google Scholar]
Syka, J. E., Coon, J. J., Schroeder, M. J., Shabanowitz, J. & Hunt, D. F.(2004). Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A101, 9528–9533.[CrossRef][Google Scholar]
Tellam, J., Connolly, G., Green, K. J., Miles, J. J., Moss, D. J., Burrows, S. R. & Khanna, R.(2004). Endogenous presentation of CD8+ T cell epitopes from Epstein–Barr virus-encoded nuclear antigen 1. J Exp Med199, 1421–1431.[CrossRef][Google Scholar]
Thompson, N. E., Hager, D. A. & Burgess, R. R.(1992). Isolation and characterization of a polyol-responsive monoclonal antibody useful for gentle purification of Escherichia coli RNA polymerase. Biochemistry31, 7003–7008.[CrossRef][Google Scholar]
Wang, C. Y. & Sugden, B.(2008). Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells. Proc Natl Acad Sci U S A105, 9639–9644.[CrossRef][Google Scholar]
Wang, J., Lindner, S. E., Leight, E. R. & Sugden, B.(2006). Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Mol Cell Biol26, 1124–1134.[CrossRef][Google Scholar]
Williams, D. K., Jr, McAlister, G. C., Good, D. M., Coon, J. J. & Muddiman, D. C.(2007). Dual electrospray ion source for electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer. Anal Chem79, 7916–7919.[CrossRef][Google Scholar]
Wu, H., Kapoor, P. & Frappier, L.(2002). Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein–Barr nuclear antigen 1. J Virol76, 2480–2490.[CrossRef][Google Scholar]
Yates, J. L. & Camiolo, S. M.(1988). Dissection of DNA replication and enhancer activation functions of Epstein–Barr virus nuclear antigen 1. Cancer Cells6, 197–205.
[Google Scholar]
Yates, J., Warren, N., Reisman, D. & Sugden, B.(1984). A cis-acting element from the Epstein–Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A81, 3806–3810.[CrossRef][Google Scholar]
Yates, J. L., Warren, N. & Sugden, B.(1985). Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells. Nature313, 812–815.[CrossRef][Google Scholar]
Yates, J. L., Camiolo, S. M., Ali, S. & Ying, A.(1996). Comparison of the EBNA1 proteins of Epstein–Barr virus and herpesvirus papio in sequence and function. Virology222, 1–13.[CrossRef][Google Scholar]
Yin, Y., Manoury, B. & Fahraeus, R.(2003). Self-inhibition of synthesis and antigen presentation by Epstein–Barr virus-encoded EBNA1. Science301, 1371–1374.[CrossRef][Google Scholar]
Young, L. S. & Rickinson, A. B.(2004). Epstein–Barr virus: 40 years on. Nat Rev Cancer4, 757–768.[CrossRef][Google Scholar]
Yu, X., Fu, S., Lai, M., Baer, R. & Chen, J.(2006). BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes Dev20, 1721–1726.[CrossRef][Google Scholar]